We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. WASHINGTON — In patients with treatment-resistant ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. “In this final follow-up from the SIMPLICITY HTN-3 trial ...

Verve Medical today announced the successful treatment of the first patient in a trial of its hypertension treatment.

Medtronic today shared new, long-term data demonstrating the clinical benefit of its Symplicity Spyral renal denervation (RDN) system.

A radiofrequency-based renal denervation system for uncontrolled hypertension got a cool reception from FDA advisors who nevertheless left the door open for regulatory approval. On Wednesday, the ...

Medtronic and Recor Medical stand to benefit from national Medicare coverage for their new device-based treatments for patients with uncontrolled high blood pressure. Medtronic and Recor have had ...

National coverage analysis is the first-of-its kind for a minimally invasive, interventional treatment for high blood pressure Milestone is supported by large public health need and robust, long-term ...

Renal denervation using radiofrequency energy is a cost-effective and high-value intervention for the treatment of uncontrolled hypertension from the perspective of the US healthcare system, an ...

Renal denervation delivers radiofrequency energy to overactive nerves in renal arteries and branch vessels. Renal denervation along with use of antihypertensive drugs leads to a sustained reduction in ...

Catheter-based, radiofrequency renal denervation is a cost-effective solution for patients with hypertension, according to a study published Aug. 13 in the Journal of the Society for Cardiovascular ...

Radiofrequency renal denervation provided progressive reductions in blood pressure at 3 years in patients on antihypertensive medication but this did not translate into fewer antihypertensive drugs, ...